Related Articles
The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells
Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes
A p110δ-specific inhibitor combined with bortezomib blocks drug resistance properties of EBV-related B cell origin cancer cells via regulation of NF-κB
Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs
Triptolide inhibits tumor growth by induction of cellular senescence